137 related articles for article (PubMed ID: 18403468)
1. Commentary on "Antiplatelet therapy for vascular interventions".
Srivastava SD
Perspect Vasc Surg Endovasc Ther; 2008 Mar; 20(1):36-7. PubMed ID: 18403468
[No Abstract] [Full Text] [Related]
2. Antiplatelet therapy for vascular interventions.
Comerota AJ; Thakur S
Perspect Vasc Surg Endovasc Ther; 2008 Mar; 20(1):28-35. PubMed ID: 18388025
[TBL] [Abstract][Full Text] [Related]
3. Long term anticoagulation or antiplatelet treatment. Giving warfarin always depends on balancing risks.
Godtfredsen J; Boysen G; Peterson P
BMJ; 2001 Jul; 323(7306):234; author reply 235-6. PubMed ID: 11496887
[No Abstract] [Full Text] [Related]
4. Antiplatelet therapy after endovascular intervention: does combination therapy really work and what is the optimum duration of therapy?
Milani RV
Catheter Cardiovasc Interv; 2009 Jul; 74 Suppl 1():S7-S11. PubMed ID: 19213064
[TBL] [Abstract][Full Text] [Related]
5. Atherothrombosis--wave goodbye to combined anticoagulation and antiplatelet therapy?
Mohler ER
N Engl J Med; 2007 Jul; 357(3):293-6. PubMed ID: 17634465
[No Abstract] [Full Text] [Related]
6. Antiplatelet agents and arterial thrombosis.
Billett HH
Cardiol Clin; 2008 May; 26(2):189-201, vi. PubMed ID: 18406994
[TBL] [Abstract][Full Text] [Related]
7. Is there less benefit from warfarin in diabetics after myocardial infarction? The numbing complexities of assessing anticoagulant and antiplatelet therapy in the diabetic patient.
Smith DA
Cardiology; 2008; 111(3):158-60. PubMed ID: 18434718
[No Abstract] [Full Text] [Related]
8. Aspirin, clopidogrel, and warfarin: is the combination appropriate and effective or inappropriate and too dangerous?
Hermosillo AJ; Spinler SA
Ann Pharmacother; 2008 Jun; 42(6):790-805. PubMed ID: 18477734
[TBL] [Abstract][Full Text] [Related]
9. Combination antiplatelet therapy in patients with peripheral arterial disease: is the best therapy aspirin, clopidogrel, or both?
Mohler ER
Catheter Cardiovasc Interv; 2009 Jul; 74 Suppl 1():S1-6. PubMed ID: 19213065
[TBL] [Abstract][Full Text] [Related]
10. [Antiplatelet and anticoagulant treatment after percutaneous transluminal angioplasty for peripheral arteriosclerosis. Survey of a Cochrane review].
Lorenzen ND; Eldrup N; Laustsen J
Ugeskr Laeger; 2007 Sep; 169(39):3279-82. PubMed ID: 17953885
[No Abstract] [Full Text] [Related]
11. Peripheral arterial procedures and postinterventional prophylaxis.
Kröger K
J Endovasc Ther; 2006 Feb; 13(1):32-8. PubMed ID: 16445321
[No Abstract] [Full Text] [Related]
12. Patients with peripheral arterial disease in the CHARISMA trial.
Cacoub PP; Bhatt DL; Steg PG; Topol EJ; Creager MA;
Eur Heart J; 2009 Jan; 30(2):192-201. PubMed ID: 19136484
[TBL] [Abstract][Full Text] [Related]
13. Use of ankle brachial index screening for selecting patients for antiplatelet drug therapy.
Krantz MJ; Coronel SM; Hiatt WR
Pharmacotherapy; 2005 Dec; 25(12):1826-8; discussion 1827-8. PubMed ID: 16305303
[No Abstract] [Full Text] [Related]
14. An aspirin a day: are we barking up the wrong willow tree?
Krantz MJ; Berger JS; Hiatt WR
Pharmacotherapy; 2010 Feb; 30(2):115-8. PubMed ID: 20099985
[No Abstract] [Full Text] [Related]
15. Pro: 'Antithrombotic therapy with warfarin, aspirin and clopidogrel is the recommended regime in anticoagulated patients who present with an acute coronary syndrome and/or undergo percutaneous coronary interventions'.
Rubboli A; Halperin JL
Thromb Haemost; 2008 Nov; 100(5):752-3. PubMed ID: 18989515
[No Abstract] [Full Text] [Related]
16. Contra: 'Antithrombotic therapy with warfarin, aspirin and clopidogrel is the recommended regimen in anticoagulated patients who present with an acute coronary syndrome and/or undergo percutaneous coronary interventions'. Not for everybody.
Roldán V; Marín F
Thromb Haemost; 2008 Nov; 100(5):754-5. PubMed ID: 18989516
[No Abstract] [Full Text] [Related]
17. Chronic antithrombotic therapy in post-myocardial infarction patients.
Nagarakanti R; Sodhi S; Lee R; Ezekowitz M
Cardiol Clin; 2008 May; 26(2):277-88, vii. PubMed ID: 18407000
[TBL] [Abstract][Full Text] [Related]
18. [Risk factor control in peripheral arterial disease can be improved. Registry study of secondary prophylactic drug therapy].
Alhadad A; Wiktorsson C; Lindblad B; Gottsäter A
Lakartidningen; 2010 Sep 29-Oct 5; 107(39):2322-5. PubMed ID: 20973248
[No Abstract] [Full Text] [Related]
19. Antiplatelet and anticoagulant therapy in patients with advanced heart failure.
Lip GY; Chung I
Thromb Res; 2005; 116(4):275-7. PubMed ID: 16038710
[No Abstract] [Full Text] [Related]
20. Atrial fibrillation and stroke risk prevention in real-life clinical practice.
Tay KH; Lip GY; Lane DA
Thromb Haemost; 2009 Mar; 101(3):415-6. PubMed ID: 19277398
[No Abstract] [Full Text] [Related]
[Next] [New Search]
